0001209191-20-024164.txt : 20200410 0001209191-20-024164.hdr.sgml : 20200410 20200410182529 ACCESSION NUMBER: 0001209191-20-024164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200410 DATE AS OF CHANGE: 20200410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Suri Anish CENTRAL INDEX KEY: 0001739130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 20787615 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-31 0 0001645460 Cue Biopharma, Inc. CUE 0001739130 Suri Anish C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 President and CSO Common Stock 2020-03-31 4 M 0 16666 0.00 A 39912 D Common Stock 2020-03-31 4 F 0 5354 0.00 D 34558 D Restricted Stock Units 2020-03-31 4 A 0 50000 0.00 A Common Stock 50000 116667 D Restricted Stock Units 2020-03-31 4 M 0 16666 0.00 D Common Stock 16666 100001 D Each restricted stock unit represents a contingent right to receive one share of common stock. Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020. /s/ Anish Suri by Mark Busch, attorney-in-fact 2020-04-10